Identification of Conserved Epitopes in SARS-CoV-2 Spike and Nucleocapsid Protein

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel virus that first occurred in Wuhan in December 2019. The spike glycoproteins and nucleocapsid proteins are the most common targets for the development of vaccines and antiviral drugs. OBJECTIVE: We herein analyze the...

Descripción completa

Detalles Bibliográficos
Autores principales: Forcelloni, Sergio, Benedetti, Anna, Dilucca, Maddalena, Giansanti, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905637/
https://www.ncbi.nlm.nih.gov/pubmed/35386436
http://dx.doi.org/10.2174/1389202923666211216162605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905637/
https://www.ncbi.nlm.nih.gov/pubmed/35386436
http://dx.doi.org/10.2174/1389202923666211216162605

Ejemplares similares